The drug reduces a growth-promoting hormone that is believed to be the reason larger dogs have much shorter life spans than smaller breeds. The fast-tracked approval will make the drug available on the market by 2026. https://themessenger.com/news/dogs-expanded-life-span-drug-fda-approval-large-breeds